The Pharmacy Technician Certification Board has awarded a research grant to assess the feasibility of a nationwide mentorship program for certified pharmacy technicians. Researchers will use interviews and survey data to evaluate interest in a mentorship model, training needs and…
Pharmacy
The FDA awarded two national priority review vouchers through its Commissioner’s National Priority Voucher pilot program on Dec. 19, bringing the total granted to 18. The latest vouchers were issued for enlicitide decanoate, an oral PCSK9 inhibitor aimed at lowering…
AstraZeneca will end U.S. commercial sales of Andexxa Dec. 22, citing safety concerns raised in postmarketing data and a recent trial, according to a Dec. 18 FDA news release. Andexxa, a recombinant factor Xa reversal agent, received accelerated approval in…
CMS has proposed two new models aimed at curbing Medicare drug spending by linking payments to international benchmarks. The proposals — GUARD for Part D drugs and GLOBE for Part B — are the latest in the CMS Innovation Center’s…
As healthcare increasingly moves toward ambulatory facilities, pharmacy departments at several health systems are expanding into the outpatient space, including Walnut Creek, Calif.-based John Muir Health. In 2024, John Muir opened a cancer infusion center to centralize care for oncology…
Advertisement
As health systems look to expand service lines, improve access and take on more complex medication management, pharmacy leaders say workforce shortages are determining where growth is possible — and where it must wait. Across community, acute and specialty settings,…
The Trump administration finalized agreements Dec. 19 with nine pharmaceutical manufacturers to offer U.S. patients prescription drug prices aligned with the lowest rates paid by other developed nations. The companies — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences,…
Hospitals and health systems face mounting pharmacy-related challenges across access, affordability, workforce and supply chain, according to the American Hospital Association’s 2026 Environmental Scan. The report, published Dec. 3, was designed as a roadmap for hospital leaders and covers financial…
Mark Cuban Cost Plus Drug Co. has added Vegzelma, a biosimilar indicated for six cancer types, to its marketplace for hospitals and other healthcare providers. The company plans to expand its biosimilar offerings amid growing demand for biologics among health…
The Pennsylvania House passed legislation Dec. 16 to preserve access to pharmacist-administered vaccines, even if federal recommendations change. The bill would allow pharmacists to provide vaccines based on guidance from state authorities — including the Pennsylvania Department of Health and…